isoquinoline has been researched along with Leukemia, Myeloid, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter-Cooper, BA; Chang, ET; Choi, EY; Elzey, BD; Lapidus, RG; Larocque, E; Naganna, N; Opoku-Temeng, C; Sintim, HO; Torregrosa-Allen, SE; Wang, M | 1 |
| Cao, D; Chen, D; Chen, L; Ding, J; Du, Z; Geng, M; Guo, Z; Huang, X; Li, J; Li, Y; Shen, J; Wang, Q; Wang, X; Xiong, B; Xu, X; Yang, H; Zhang, Z; Zheng, X | 1 |
2 other study(ies) available for isoquinoline and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; fms-Like Tyrosine Kinase 3; Humans; Isoquinolines; Leukemia, Myeloid, Acute; Mice; Molecular Structure; Mutation; Naphthyridines; Protein Kinase Inhibitors; src-Family Kinases | 2019 |
Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid Leukemia.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Enzyme Inhibitors; G1 Phase Cell Cycle Checkpoints; Humans; Isoquinolines; Leukemia, Myeloid, Acute; Mice; Models, Molecular; Protein Conformation; Protein-Arginine N-Methyltransferases; Stereoisomerism; Tissue Distribution; Xenograft Model Antitumor Assays | 2019 |